Dow Jones

39 150,33

0,04%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
VIA Pharmaceuticals Inc (CE) (VIAP)
VIA Pharmaceuticals Inc (CE) (VIAP) Actualités

VIAP

VIA Pharmaceuticals (CE) (VIAP)

VIA Pharmaceuticals Inc (CE)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:VIAP

Date	Heure	Source	Titre	Symbole	Société
13/06/2011	14h00	Marketwired	VIA Pharmaceuticals Announces First-in-Human Dosing of VIA-3196 for Treatment of Dyslipidemia	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
25/03/2011	22h03	Edgar (US Regulatory)	Termination of Registration of a Class of Security under Section 12(g) (15-12G)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
24/03/2011	20h58	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
11/02/2011	20h55	Edgar (US Regulatory)	Statement of Ownership (SC 13G)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
18/01/2011	23h09	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
03/01/2011	12h01	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
30/12/2010	19h14	Edgar (US Regulatory)	Post-Effective Amendment to Registration Statement (POS AM)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
30/12/2010	19h06	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
17/11/2010	22h47	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
17/11/2010	21h41	Edgar (US Regulatory)	Amended Small Company Offering and Sale of Securities Without Registration (D/A)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
17/11/2010	21h37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
15/11/2010	22h30	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
20/05/2010	13h30	Marketwired	VIA Pharmaceuticals and MHI Announce Publication of VIA-2291 5-Lipoxygenase Inhibitor Clinical Study Data in Circulation: Cardio	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
30/04/2010	23h05	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
31/03/2010	22h01	Marketwired	VIA Pharmaceuticals Announces Strategic Restructuring and Financing	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
26/02/2010	15h45	Edgar (US Regulatory)	(25-NSE)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)
16/02/2010	19h28	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	USOTC:VIAP	VIA Pharmaceuticals Inc (CE)